TriStar Health Partners

TVA Medical, Inc. is a medical device company based in Austin, Texas, focused on developing catheter-based solutions for end-stage renal disease and peripheral vascular diseases. Founded in 2009, the company specializes in innovative, minimally invasive therapies, notably through its everlinQ endoAVF system. This system facilitates the creation of an arteriovenous fistula using an endovascular approach, allowing for hemodialysis in patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. TVA Medical operates as a subsidiary of Becton, Dickinson and Company and has received funding from Santé Ventures.

MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.

NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.

Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Advanced Catheter Therapies, Inc. is an early-stage medical device company focused on the research and development of catheter technologies designed to address various vascular diseases, such as thrombosis, inflammation, occlusions, and restenosis. The company's key product, the Occlusion Perfusion Catheter, is a multi-lumen balloon catheter that temporarily restricts blood flow to enable localized delivery of therapeutic agents within the peripheral and coronary vasculature. Additionally, Advanced Catheter Therapies is developing devices specifically aimed at preventing restenosis, or the re-blockage of blood vessels, as well as catheters for endovascular debulking, which involves clearing blocked blood vessels. Founded in 2008 and based in Chattanooga, Tennessee, the company was previously known as Atlanta Catheter Therapies, Inc. before rebranding in October 2011.

MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.

InvisionHeart is a company focused on enhancing cardiac care through its innovative hardware and software system designed to capture and manage cardiac data. Originating from research conducted by physicians and engineers at Vanderbilt University, the technology addresses real-world clinical challenges faced by heart patients. InvisionHeart offers a mobile electrocardiograph system that allows a network of healthcare professionals, including physicians, nurses, and technicians, to securely access and annotate patient electrocardiogram tracings. The company's leadership, consisting of experienced professionals in both software and hardware development, along with a strong clinical advisory team, is dedicated to improving the care of heart patients in diverse environments.

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Bjond Inc., founded in 2012 and based in Columbus, Ohio, operates in the technology sector with a focus on healthcare software. The company specializes in automated workflow and real-time decision support tools designed to assist patients in making informed choices and facilitating behavior change. Its software provides a dynamic and engaging platform for users, allowing individuals and businesses to create interactive content and expert workflows with minimal technical expertise. By leveraging a continuous cycle of data-driven care, Bjond aims to enhance patient outcomes and improve overall quality of life across various industries and situations.

GenomOncology, LLC is a Cleveland-based genomics technology and services company dedicated to enhancing precision medicine by converting next-generation sequencing (NGS) data into actionable insights for clinicians and researchers. The company offers the GO Clinical Workbench, a decision support tool that translates raw sequencing data into detailed clinical reports based on the molecular profile of each patient's tumor genome. Additionally, GenomOncology provides GenomAnalytics, a research platform facilitating rapid, near real-time genome analysis and exploration for new discoveries. IgniteIQ is another solution offered, which extracts clinically relevant data from various reports and converts it into discrete data elements. The company also supports assay validation, integration with laboratory information systems, and custom feature development. Established in 2012, GenomOncology aims to improve patient outcomes through advanced data interpretation in oncology.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.

Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.

VenX Medical LLC is a medical device company based in Nashville, Tennessee, specializing in the treatment of varicose veins associated with venous insufficiency. Founded in 2009, the company develops innovative devices utilizing nanophlebectomy technology for the treatment of spider and reticular veins. Its primary offerings include VenX Reach, a minimally invasive disposable device designed for horizontal phlebectomy, and a handheld device that disrupts the vein structure to promote coagulation. These devices can be used independently or as adjuncts to other vein therapies such as endovenous ablation and sclerotherapy. Through its advanced medical technology, VenX Medical aims to provide effective solutions for patients suffering from venous disorders.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

TVA Medical, Inc. is a medical device company based in Austin, Texas, focused on developing catheter-based solutions for end-stage renal disease and peripheral vascular diseases. Founded in 2009, the company specializes in innovative, minimally invasive therapies, notably through its everlinQ endoAVF system. This system facilitates the creation of an arteriovenous fistula using an endovascular approach, allowing for hemodialysis in patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. TVA Medical operates as a subsidiary of Becton, Dickinson and Company and has received funding from Santé Ventures.

Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Cerebrotech Medical Systems, Inc. specializes in the development of non-invasive monitoring technology aimed at patients recovering from strokes or traumatic brain injuries. The company's flagship product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which are critical indicators in various neurological conditions. By continuously monitoring brain fluids, the device allows healthcare providers to identify potential increases in intracranial pressure before they escalate, enabling timely medical intervention to prevent further brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes in neurological assessments and treatment.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diabetes Care Group, Inc. is a provider of specialized clinical care services for individuals with diabetes, based in Jackson, Mississippi. Founded in 1986, the company focuses on delivering an interdisciplinary model that integrates medical management, patient education, and behavioral modification. Their services include personalized counseling, diet and nutrition guidance, blood glucose monitoring, and point-of-care laboratory testing, all aimed at enhancing patient self-management and clinical outcomes. With a commitment to reducing the overall medical and social costs associated with diabetes, Diabetes Care Group employs a team of experienced professionals, including board-certified physicians, registered nurse educators, and registered dieticians. This integrated approach is backed by over ten years of research and clinical experience, demonstrating significant improvements in health outcomes for patients facing the challenges of diabetes.

Cerebrotech Medical Systems, Inc. specializes in the development of non-invasive monitoring technology aimed at patients recovering from strokes or traumatic brain injuries. The company's flagship product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which are critical indicators in various neurological conditions. By continuously monitoring brain fluids, the device allows healthcare providers to identify potential increases in intracranial pressure before they escalate, enabling timely medical intervention to prevent further brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes in neurological assessments and treatment.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Diabetes Care Group, Inc. is a provider of specialized clinical care services for individuals with diabetes, based in Jackson, Mississippi. Founded in 1986, the company focuses on delivering an interdisciplinary model that integrates medical management, patient education, and behavioral modification. Their services include personalized counseling, diet and nutrition guidance, blood glucose monitoring, and point-of-care laboratory testing, all aimed at enhancing patient self-management and clinical outcomes. With a commitment to reducing the overall medical and social costs associated with diabetes, Diabetes Care Group employs a team of experienced professionals, including board-certified physicians, registered nurse educators, and registered dieticians. This integrated approach is backed by over ten years of research and clinical experience, demonstrating significant improvements in health outcomes for patients facing the challenges of diabetes.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.

Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.

Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.